Drug Type saRNAs |
Synonyms |
Target |
Mechanism SMN2 stimulants(Survival motor neuron protein stimulants) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization Ractigen TherapeuticsStartup |
Active Organization Ractigen TherapeuticsStartup |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Spinal Muscular Atrophy | Preclinical | CN | Ractigen TherapeuticsStartup | 28 Feb 2022 |